Cargando…
Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases
Myocarditis associated with the use of immune checkpoint inhibitors (ICI) is a rare manifestation of their cardiotoxicity, but is characterized by a high mortality rate. A literature search was conducted using PubMed using keywords, which resulted in the selection of 679 scientific works, from which...
Autor principal: | Zotova, Liudmila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093455/ https://www.ncbi.nlm.nih.gov/pubmed/37046461 http://dx.doi.org/10.3390/diagnostics13071243 |
Ejemplares similares
-
Immune checkpoint inhibitor–associated myocarditis: Case reports and a review of the literature
por: Osinga, T. E., et al.
Publicado: (2022) -
Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases
por: Matzen, Emma, et al.
Publicado: (2021) -
Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis
por: Jiménez-Alejandre, Rosa, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review
por: Wang, Dong, et al.
Publicado: (2023) -
Clinical Characteristics and Outcomes in Immune Checkpoint Inhibitor Therapy-Associated Myocarditis
por: Thakker, Ravi A., et al.
Publicado: (2021)